Nasopharyngeal carcinoma‐associated Epstein–Barr virus‐encoded oncogene latent membrane protein 1 potentiates regulatory T‐cell function-Reference-Cited by-同舟云学术

Nasopharyngeal carcinoma‐associated Epstein–Barr virus‐encoded oncogene latent membrane protein 1 potentiates regulatory T‐cell function

Published:2007-03-20 Issue:5 Volume:85 Page:370-377
ISSN:0818-9641
Container-title:Immunology & Cell Biology
language:en
Short-container-title:Immunol Cell Biol

Author:

Pai Saparna¹²,O'Sullivan Brendan¹,Abdul‐Jabbar Ibtissam¹,Peng Judy¹,Connoly Geoff²,Khanna Rajiv²,Thomas Ranjeny¹

Affiliation:

1. Princess Alexandra Hospital, University of Queensland Brisbane Queensland Australia

2. Tumour Immunology Laboratory, Division of Infectious Diseases and Immunology, Queensland Institute of Medical Research Queensland Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1038/sj.icb.7100046

Reference51 articles.

1. Infectious Mononucleosis: Appearance of Neutralizing Antibody to Epstein-Barr Virus Measured by Inhibition of Formation of Lymphoblastoid Cell Lines

2. The Epstein‐Barr virus latent membrane protein‐1 (LMP1) mediates activation of NF‐kappa B and cell surface phenotype via two effector regions in its carboxy‐terminal cytoplasmic domain;Huen DS;Oncogene,1995

3. Role of the TRAF Binding Site and NF-κB Activation in Epstein-Barr Virus Latent Membrane Protein 1-Induced Cell Gene Expression

4. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF- B

5. RelB Nuclear Translocation Mediated by C-Terminal Activator Regions of Epstein-Barr Virus-Encoded Latent Membrane Protein 1 and Its Effect on Antigen-Presenting Function in B Cells

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook;Cancer and Metastasis Reviews;2024-03-02

2. Pathogenesis and therapeutic implications of EBV-associated epithelial cancers;Frontiers in Oncology;2023-10-02

3. Celebrating 100 years of Immunology & Cell Biology – a special focus on the field of tumor immunology in Australia;Immunology & Cell Biology;2023-09-11

4. The immune escape mechanism of nasopharyngeal carcinoma;The FASEB Journal;2023-06-26

5. The role of Epstein–Barr virus in nasopharyngeal carcinoma;Frontiers in Microbiology;2023-02-09